Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction

Journal of the American College of Cardiology

Volumn 46, Issue 1, 2005, Pages 125-133

  Van Der Meer, Peter ^a   Lipsic, Erik ^a   Henning, Robert H ^a   Boddeus, Kristien ^a   Van Der Velden, Jolanda ^b   Voors, Adriaan A ^a   Van Veldhuisen, Dirk J ^a   Van Gilst, Wiek H ^a   Schoemaker, Regien G ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ERYTHROPOIETIN; ISOPROTEIN; MYOSIN HEAVY CHAIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART FAILURE; HEART FUNCTION; HEART HYPERTROPHY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART PERFORMANCE; HEMODYNAMICS; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIAC OUTPUT; CARDIOMYOPATHY, DILATED; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ERYTHROPOIETIN; MALE; MYOCARDIAL INFARCTION; MYOSIN HEAVY CHAINS; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY;

EID: 21344459065     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.03.044     Document Type: Article

References (46)

1. A. Anagnostou, Z. Liu, M. Steiner Erythropoietin receptor mRNA expression in human endothelial cells Proc Natl Acad Sci U S A 91 1994 3974 3978
2. Z.Z. Chong, J.Q. Kang, K. Maiese Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases Circulation 106 2002 2973 2979
3. P. van der Meer, A.A. Voors, E. Lipsic, W.H. van Gilst, D.J. van Veldhuisen Erythropoietin in cardiovascular diseases Eur Heart J 25 2004 285 291
4. G.L. Wright, P. Hanlon, K. Amin, C. Steenbergen, E. Murphy, M.O. Arcasoy Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury FASEB J 18 2004 1031 1033
5. R.A. De Boer, Y.M. Pinto, D.J. van Veldhuisen The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure the role of microvascular growth and abnormalities Microcirculation 10 2003 113 126
6. D. Ribatti, M. Presta, A. Vacca Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo Blood 93 1999 2627 2636
7. K. Jaquet, K. Krause, M. Tawakol-Khodai, S. Geidel, K. Kuck Erythropoietin and VEGF exhibit equal angiogenic potential Microvasc Res 64 2002 326 333
8. L. Wang, Z.G. Zhang, Y. Wang, R.L. Zhang, M. Chopp Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats Stroke 35 2004 1732 1737
9. M. Sakanaka, T.C. Wen, S. Matsuda In vivo evidence that erythropoietin protects neurons from ischemic damage Proc Natl Acad Sci U S A 95 1998 4635 4640
10. A.L. Siren, M. Fratelli, M. Brines Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress Proc Natl Acad Sci U S A 98 2001 4044 4049
11. E. Lipsic, P. van der Meer, R.H. Henning Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion J Cardiovasc Pharmacol 44 2004 473 479
12. C.J. Parsa, A. Matsumoto, J. Kim A novel protective effect of erythropoietin in the infarcted heart J Clin Invest 112 2003 999 1007
13. P. van der Meer, E. Lipsic, R.H. Henning Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury Eur J Heart Fail 6 2004 853 859
14. Z.Q. Cai, G.L. Semenza Phosphatidylinositol-3-kinase signaling is required for erythropoietin-mediated acute protection against myocardial ischemia/reperfusion injury Circulation 109 2004 2050 2053
15. C.J. Parsa, J. Kim, R.U. Riel Cardioprotective effects of erythropoietin in the reperfused ischemic heart - a potential role for cardiac fibroblasts J Biol Chem 279 2004 20655 20662
16. R. Van Kerckhoven, R. van Veghel, P.R. Saxena, R.G. Schoemaker Pharmacological therapy can increase capillary density in post-infarction remodeled rat hearts Cardiovasc Res 61 2004 620 629
17. J.M. Pfeffer, M.A. Pfeffer, P.J. Fletcher, E. Braunwald Progressive ventricular remodeling in rat with myocardial infarction Am J Physiol 260 1991 H1406 H1414
18. Y. Wang, Z.G. Zhang, L. Wang, R.L. Zhang, M. Chopp Erythropoietin enhances neurogenesis and angiogenesis in the brain and improves functional recovery after embolic stroke in the adult rat Stroke 35 2004 239
19. R.A. De Boer, Y.M. Pinto, A.J. Suurmeijer Increased expression of cardiac angiotensin II type 1 (AT[1]) receptors decreases myocardial microvessel density after experimental myocardial infarction Cardiovasc Res 57 2003 434 442
20. A.E. Loot, A.J.M. Roks, R.H. Henning Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats Circulation 105 2002 1548 1550
21. H.J.M.G. Nelissen-Vrancken, M.C. Kuizinga, M.J.A.P. Daemen, J.F.M. Smits Early captopril treatment inhibits DNA synthesis in endothelial cells and normalization of maximal coronary flow in infarcted rat hearts Cardiovasc Res 40 1998 156 164
22. E.A.J. Kalkman, Y.M. Bilgin, P. van Haren, R.J. vanSuylen, P.R. Saxena, R.G. Schoemaker Determinants of coronary reserve in rats subjected to coronary artery ligation or aortic banding Cardiovasc Res 32 1996 1088 1095
23. J. van der Velden, A.F.M. Moorman, G.J.M. Stienen Age-dependent changes in myosin composition correlate with enhanced economy of contraction in guinea-pig hearts J Physiol 507 1998 497 510
24. T. Sladek, J. Sladkova, F. Kolar The effect of AT1 receptor antagonist on chronic cardiac response to coronary artery ligation in rats Cardiovasc Res 31 1996 568 576
25. L. Calvillo, R. Latini, J. Kajstura Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling Proc Natl Acad Sci U S A 100 2003 4802 4806
26. C. Moon, M. Krawczyk, D. Ahn Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats Proc Natl Acad Sci U S A 100 2003 11612 11617
27. T. Scarabelli, A. Stephanou, N. Rayment Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury Circulation 104 2001 253 256
28. R.G. Carlini, A.A. Reyes, M. Rothstein Recombinant-human-erythropoietin stimulates angiogenesis in-vitro Kidney Int 47 1995 740 745
29. C. Heeschen, A. Aicher, R. Lehmann Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization Blood 102 2003 1340 1346
30. K. Amann, M. Buzello, A. Simonaviciene Capillary/myocyte mismatch in the heart in renal failure - a role for erythropoietin? Nephrol Dial Transplant 15 2000 964 969
31. T.J. Herron, K.S. McDonald Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments Circ Res 90 2002 1150 1152
32. F.H. Bahlmann, K. DeGroot, T. Duckert Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin - rapid communication Kidney Int 64 2003 1648 1652
33. H. Eder, B. Rosslenbroich, K. Failing A dose-dependent effect of recombinant erythropoietin on the reticulocyte population of rats Blut 59 1989 184 187
34. F.T. Ruschitzka, R.H. Wenger, T. Stallmach Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin Proc Natl Acad Sci U S A 97 2000 11609 11613
35. W.C. Wu, S.S. Rathore, Y. Wang, M.J. Radford, H.M. Krumholz Blood transfusion in elderly patients with acute myocardial infarction N Engl J Med 345 2001 1230 1236
36. C. Wiessner, P.R. Allegrini, D. Ekatodramis, U.R. Jewell, T. Stallmach, M. Gassmann Increased cerebral infarct volumes in polyglobulic mice overexpressing erythropoietin J Cereb Blood Flow Metab 21 2001 857 864
37. R.F. Wolf, L.S. Gilmore, P. Friese, T. Downs, S.A. Burstein, G.L. Dale Erythropoietin potentiates thrombus development in a canine arterio-venous shunt model Thromb Haemost 77 1997 1020 1024
38. S.D. Roger, L.R. Baker, A.E. Raine Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO) Clin Nephrol 39 1993 103 110
39. J.J. McMurray What are the clinical consequences of anemia in patients with chronic heart failure? J Card Fail 10 2004 S10 S12
40. T.B. Horwich, G.C. Fonarow, M.A. Hamilton, W.R. MacLellan, J. Borenstein Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure J Am Coll Cardiol 39 2002 1780 1786
41. P. van der Meer, A.A. Voors, E. Lipsic, T.D.J. Smilde, W.H. van Gilst, D.J. van Veldhuisen Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure J Am Coll Cardiol 44 2004 63 67
42. D.S. Silverberg, D. Wexler, D. Sheps The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron a randomized controlled study J Am Coll Cardiol 37 2001 1775 1780
43. D.M. Mancini, S.D. Katz, C.C. Lang, J. LaManca, A. Hudaihed, A.S. Androne Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure Circulation 107 2003 294 299
44. H. Ehrenreich, M. Hasselblatt, C. Dembowski Erythropoietin therapy for acute stroke is both safe and beneficial Mol Med 8 2002 495 505
45. F.H. Bahlmann, R. Song, S.M. Boehm Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure Circulation 110 2004 1006 1012
46. F. Fiordaliso, S. Chimenti, L. Staszewsky A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury Proc Natl Acad Sci U S A 102 2005 2046 2051